-
Biocon recommends a dividend of Rs. 5 per share 2012-04-28 09:38:06
Biocon posts Revenues at Rs 2,148 Crores; EBITDA at Rs 579 Crores; PAT at Rs 338 Crores Commenting on the results, Chairman and Managing Director of Biocon Kiran Mazumdar-Shaw stated, “I am pleased with the overall performance that we have...
Keywords: insulin commercialization, Biocon, Biocon, Biocon
Read More